Human tumor necrosis factor (hTNF) mediates a variety of biologic activities, which are dependent on the attachment of hTNF to cell-surface receptors. To identify regions of the hTNF protein involved in binding hTNF to its receptor, we prepared five synthetic peptides , hTNF-(1-31), hTNF-(65-79), hTNF-(98-111), and hTNF-(124-141)] and two hydroxylamine cleavage fragments and hTNF-(40-157)] of hTNF. The hTNF-synthetic peptides and hTNF fragments were tested in hTNF receptor binding assays and in two biologic assays: cytolysis of tumor cells and suppression of lipoprotein lipase in adipocytes. Neither the synthetic peptides nor hTNF fragments were active agonists or antagonists in these assays. The synthetic peptides were also conjugated to thyroglobulin, and peptide-specific antisera were raised. All five peptide-thyroglobulin conjugates induced antibody responses to the immunizing peptide and to hTNF. Each antiserum was tested for antagonist activity in hTNF binding assays. Only antisera raised against hTNF-(1-15) or hTNF-(1-31) and antisera against whole hTNF blocked binding. IgGs purified from these three antisera also block hTNF-induced cytolysis and lipoprotein lipase suppression. We conclude that antibodies that recognize the Nterminus of hTNF block the attachment of hTNF to its cellular receptor and inhibit the biologic effects of hTNF.Tumor necrosis factor (TNF) is a cytokine secreted by activated macrophages. Carswell et al.(1) originally showed that TNF can promote the lysis of tumor cells in vitro and in vivo. Beutler et al. (2) showed that TNF was identical to another macrophage-derived protein termed cachectin. More recently, TNF has been shown to mediate a variety of biologic effects including the following: endotoxin-induced shock (3), suppression of lipoprotein lipase (LPL) activity in preadipocytes (2), stimulation of collagenase activity and prostaglandin E2 production by synovial cells (4), enhanced proliferation of fibroblasts in vitro (5), stimulation of bone resorption (6), stimulation of interleukin 1 production (7), and induction of cachexia in nude mice (8). Human TNF (hTNF) cDNAs and genomic DNA clones have been isolated and sequenced (9,10). Using these cloned genes several investigators have expressed recombinant hTNF protein and validated the diversity of biologic activities attributed to TNF (11).TNF-specific cell-surface receptors are present on several types of cells (12,13). The binding of TNF to these receptors is believed necessary for induction of the biologic effects of TNF. Therefore, it should be possible to inhibit the biologic activities of TNF by blocking the association of TNF with its cellular receptors. We examined the deduced amino acid sequence of hTNF and selected regions of the protein that might be involved in receptor-ligand interactions. To evaluate the importance of these regions in mediating the interaction of hTNF with its receptor we used two strategies. (i) Synthetic peptides were prepared based on the amino acid sequence in these regions; and the...